Show 1362: Lowdown on New Medicines for Treating Obesity Part 2
This week\u2019s radio show is the second of a two-part series on new medicines for treating obesity. This episode features Dr. Robert Lustig, neuroendocrinologist and anti-obesity crusader. He discusses the uses and disadvantages of drugs such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro). In addition, he offers a completely different way to combat obesity. You [\u2026]